Dr. Kremer has received consulting fees, speaking fees, and/or honoraria from Bristol-Myers Squibb, Centocor, Roche, and UCB (less than $10,000 each).
Interpreting registry-derived drug studies: Does societal context matter?
Article first published online: 29 OCT 2009
Copyright © 2009 by the American College of Rheumatology
Arthritis & Rheumatism
Volume 60, Issue 11, pages 3155–3157, November 2009
How to Cite
Kremer, J. M. and Greenberg, J. (2009), Interpreting registry-derived drug studies: Does societal context matter?. Arthritis & Rheumatism, 60: 3155–3157. doi: 10.1002/art.24880
- Issue published online: 29 OCT 2009
- Article first published online: 29 OCT 2009
- Manuscript Accepted: 11 JUL 2009
- Manuscript Received: 8 MAY 2009